Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Frontline
FRO
$9.02B
| $36.5M | 0.03% |
2,856,605
+82,917
| +3% | +$903K |
|
|
WCG
677
DELISTED
Wellcare Health Plans, Inc.
WCG
| $36.5M | 0.03% |
+110,400
| New | +$33.1M |
|
678
ATN International
ATNI
$491M
| $36.3M | 0.03% |
656,200
-44,300
| -6% | -$2.52M |
|
679
HEICO Corp
HEI
$51.9B
| $36.3M | 0.03% |
318,064
+198,900
| +167% | +$24.5M |
|
680
Lennar Class A
LEN
$21.1B
| $36.2M | 0.03% |
+671,071
| New | +$38.3M |
|
681
Cracker Barrel
CBRL
$1.31B
| $36.2M | 0.03% |
235,500
-46,132
| -16% | -$7.26M |
|
682
VanEck Gold Miners ETF
GDX
$26.9B
| $36.2M | 0.03% |
1,235,800
+798,800
| +183% | +$21.8M |
|
683
Barrett Business Services
BBSI
$800M
| $36.1M | 0.03% |
1,596,800
-14,000
| -0.9% | -$310K |
|
684
Toronto Dominion Bank
TD
$203B
| $36M | 0.03% |
640,641
-940,414
| -59% | -$53.3M |
|
685
Ituran Location and Control
ITRN
$1.06B
| $35.9M | 0.03% |
1,430,100
-38,700
| -3% | -$947K |
|
686
Cohu
COHU
$2.76B
| $35.9M | 0.03% |
1,571,663
+246,609
| +19% | +$4.43M |
|
687
RadNet
RDNT
$6.08B
| $35.9M | 0.03% |
1,766,070
-62,533
| -3% | -$1.07M |
|
|
IMOS
688
ChipMOS TECHNOLOGIES
IMOS
$2.01B
| $35.7M | 0.03% |
1,579,488
+18,088
| +1% | +$399K |
|
|
BDN
689
Brandywine Realty Trust
BDN
$542M
| $35.7M | 0.03% |
2,265,998
+244,300
| +12% | +$3.69M |
|
690
Labcorp
LH
$26.2B
| $35.7M | 0.03% |
245,493
+235,017
| +2,243% | +$33.9M |
|
691
Sanmina
SANM
$11.1B
| $35.7M | 0.03% |
1,041,441
-137,800
| -12% | -$4.41M |
|
|
ROIC
692
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $35.6M | 0.03% |
2,014,368
+275,768
| +16% | +$4.99M |
|
693
TD Synnex
SNX
$20.4B
| $35.5M | 0.03% |
550,656
-71,000
| -11% | -$4.28M |
|
694
WesBanco
WSBC
$4.1B
| $35.3M | 0.03% |
935,298
+77,934
| +9% | +$2.91M |
|
695
MGE Energy Inc
MGEE
$3.06B
| $35.2M | 0.03% |
446,850
-14,000
| -3% | -$1.08M |
|
|
QIWI
696
DELISTED
QIWI PLC
QIWI
| $35.2M | 0.03% |
1,817,971
+210,891
| +13% | +$4.12M |
|
697
Hubbell
HUBB
$26.8B
| $35.1M | 0.03% |
237,395
+117,695
| +98% | +$16.8M |
|
698
Bank of Montreal
BMO
$129B
| $34.9M | 0.03% |
450,700
+137,255
| +44% | +$10.3M |
|
699
NatWest
NWG
$76.9B
| $34.9M | 0.03% |
5,034,250
-35,657
| -0.7% | -$223K |
|
|
EGOV
700
DELISTED
NIC Inc
EGOV
| $34.9M | 0.03% |
1,559,833
+126,201
| +9% | +$2.76M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.